Fundamental Analysis
43 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +65.7% | +21.9% | 2 / 3 | -6.2% | +2.13 pp | +1.89 pp | +8.8% | 0.89 | 8.36 | 11.091 | −6,2% | 465 | +70,5% | 8.36 | 5.18 | +61,4% |
| Pts | 12 | 0 | 8 | 0 | 8 | 8 | 0 | 6 | 4 | |||||||
Valuation annotation:Price: 9.700 (close price on 2026-10-19)EPS (TTM): 1.160
Financial charts
1.Revenue & growth
VND bn12.512Q2/26
1.Revenue & growth
VND bn12.512Q2/26
2.Profit & growth
VND bn433Q2/26
3.Profit mix (Penman)
VND bn961Q2/26
4.Margins & cost structure
%4.7%Q2/26
5.Returns & cash cycle
% · days3.9%Q2/26
6.Earnings quality & cash
VND bn219Q2/26
7.Asset structure
VND bn29.010Q2/26
8.Funding & debt health
VND bn · times29.010Q2/26
9.Revenue backlog
VND bn289Q2/26
10.Valuation
times · %8,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %639Q2/26
Adjusted EPS growth, latest quarter
65.6%
Average adjusted EPS growth, 3 quarters
21.9%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26